إسرائيل - العبرية - Ministry of Health

novartis pharma services ag - terbinafine hydrochloride 281.25 mg - tablets - terbinafine - fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum. oral lamisil should only be used to treat extensive, severe ringworm infections ( tinea corporis, tinea cruris and tinea pedis). oral lamisil is not effective against vaginal candidiasis or pityriasis (tinea) versicolor. onychomycoses ( tinea unguium, ringworm of the nails) due to infecton with dermatophyte organisms ( hyphomycetes).

إسرائيل - العبرية - Ministry of Health

novartis pharma services ag - terbinafine hydrochloride 281.25 mg - tablets - terbinafine - fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum. oral lamisil should only be used to treat extensive, severe ringworm infections ( tinea corporis, tinea cruris and tinea pedis). oral lamisil is not effective against vaginal candidiasis or pityriasis (tinea) versicolor. onychomycoses ( tinea unguium, ringworm of the nails) due to infecton with dermatophyte organisms ( hyphomycetes).

إسرائيل - العبرية - Ministry of Health

novartis pharma services ag - methylergometrine maleate 125 mcg - tablets - methylergometrine - prevention or treatment of uterine haemorrhage.

إسرائيل - العبرية - Ministry of Health

novartis pharma services ag - tetracosactide hexaacetate 1 mg/ml - suspension for injection - tetracosactide - collagen diseases, neurological diseases, chronic skin disorders.

إسرائيل - العبرية - Ministry of Health

novartis pharma services ag - calcitonin salmon 2200 iu/ml - solution - calcitonin (salmon synthetic) - bone pain associated with osteolysis due to malignancies. paget's disease of bone only in patients who do not respond to alternative treatments or for whom such treatments are not suitable. neurodystrophic disorders.

إسرائيل - العبرية - Ministry of Health

novartis pharma services ag - telbivudine 600 mg - film coated tablets - telbivudine - treatment of chronic hepatitis b in patients with evidence of viral replication and active liver inflammation in adults over 16 years of age.the following points should be considered when initiating therapy with sebivo:- for hbeag - positive patients, sebivo treatment should only be initiated in patients with baseline hbv dna < 9log 10 copies/ml and baseline alt>or= 2x uln.- for hbeag - negative patients, sebivo treatment should only be initiated in patients with baseline hbv dna < 7log 10 copies/ml.

إسرائيل - العبرية - Ministry of Health

novartis pharma services ag - verteporfin 15 mg/vial - solution for infusion - verteporfin - visudyne is indicated for the treatment of patients with predominantly classic or occult subfoveal choroidal neovascularization due to age related macular degeneration, or with subfoveal choroidal neovascularization caused by other macular diseases.

إسرائيل - العبرية - Ministry of Health

novartis pharma services ag - imatinib as mesylate 100 mg - capsules - imatinib - treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ - cml) in chronic phase, accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist).

إسرائيل - العبرية - Ministry of Health

novartis pharma services ag - imatinib as mesylate 100 mg - film coated tablets - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic l

إسرائيل - العبرية - Ministry of Health

novartis pharma services ag - interferon beta 1b 0.3 mg - powder and solvent for solution for injection - interferon beta-1b - extavia is indicated for the treatment of:• for use in relapsing-remitting and relapsing-progressive multiple sclerosis. it is designated for ambulatory patients who meet criteria for clinically definite and for laboratory supported definite ms, and who have experienced at least two exacerbations over the last two years.extavia reduces the frequency of clinical exacerbations.in secondary progressive multiple sclerosis extavia is indicated for slowing progression of disease and for the reduction of frequency of clinical relapses. compared with placebo, patients receiving extavia showed a statistically significant delay in time to progression of multiple sclerosis. the treatment effect occurred in patients with and without relapses and at all levels of disability investigated (patients with mild disease and those unable to walk were not studied). patients receiving extavia also showed a statistically significant delay in the time to become wheelchair-bound when compared with placebo. see also section 5.1 “pharm